T2 Biosystems jumps on FDA nod for sepsis tests

Shares of T2 Biosystems jump nearly 10% after the FDA approves its MR-based tests designed to detect sepsis in a matter of hours rather than days.

Food & Drug Administration (FDA), T2 Biosystems Inc.

News Well, 510(k), Diagnostics, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1mRUgap